Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Google News
clinicalleader.com > doc > expanded-access-and-rollover-design-help-cytodyn-reach-high-need-cancer-patients-0001

Expanded Access And Rollover Design Help CytoDyn Reach High-Need Cancer Patients

2+ day, 20+ hour ago   (754+ words) Guest Column | July 24, 2026 A conversation among CytoDyn CFO Robert E. Hoffman, CytoDyn CEO Jay Lalezari, MD, and Clinical Leader Executive Editor Abby Proch In this Q&A, CEO Jay Lalezari and CFO Robert E. Hoffman discuss the company’s clinical programs and how…...

EdClinical
clinicalleader.com > doc > why-protocol-complexity-is-slowing-first-patient-in-and-how-small-sponsors-can-fix-start-up-inefficiencies-0001

Why Protocol Complexity Is Slowing First Patient In — And How Small Sponsors Can Fix Start-Up Inefficiencies

3+ day, 20+ hour ago   (1430+ words) Guest Column | July 23, 2026 By Jessica Cordes, Senior Consultant for Clinical Operations, Clinical Excellence GmbH For small and emerging biotech companies, this issue is particularly critical. Limited internal experience, resource constraints, and reliance on external partners make it difficult to absorb…...

EdClinical
clinicalleader.com > doc > pharma-r-d-pipeline-productivity-three-ways-to-enhance-bandwidth-and-efficiency-0001

Pharma R&D Pipeline Productivity: Three Ways To Enhance Bandwidth And Efficiency

4+ day, 20+ hour ago   (333+ words) Guest Column | July 22, 2026 By Naveed Panjwani, pharma R&D consulting lead, PA Consulting The global pharmaceutical industry faces persistent challenges to the productivity of its R&D pipelines. Recent years have seen a stabilization of a decade-long decline, with R…...

EdClinical
clinicalleader.com > doc > the-u-s-clinical-trial-recruiting-pipeline-report-june-0001

The U.S. Clinical Trial Recruiting Pipeline Report – June 2026

4+ day, 20+ hour ago   (505+ words) Guest Column | July 22, 2026 How have the number and type of clinical trials coming in and out of the U.S. pipeline changed over the past few months? To find out, Find Clinical Trials by WhichTrial.com developed the May-June version of its…...

EdClinical
clinicalleader.com > doc > when-one-trial-leads-to-rethinking-them-all-0001

When One Trial Leads To Rethinking Them All

4+ day, 22+ hour ago   (459+ words) From The Editor | July 22, 2026 By Dan Schell, Chief Editor, Clinical Leader It began on a COVID ward in Oxford during the earliest days of the pandemic. It led to a clinical trial that influenced treatment around the world. But perhaps…...

EdClinical
clinicalleader.com > doc > rapid-expansion-of-peptide-and-nanobody-drug-conjugates-0001

Rapid Expansion Of Peptide And Nanobody Drug Conjugates

5+ day, 50+ min ago   (146+ words) Clinical Leader Rapid Expansion Of Peptide And Nanobody Drug Conjugates Peptide and nanobody drug conjugates are moving from specialized research concepts to a more visible segment of the global development pipeline. A Citeline analysis presented at PEGS 2026 identified 106 active programs…...

EdClinical
clinicalleader.com > doc > positioning-early-phase-cns-trials-for-regulatory-and-investor-success-strategic-implications-of-the-single-phase-approval-paradigm-0001

Positioning Early Phase CNS Trials For Regulatory And Investor Success: Strategic Implications Of The Single Phase 3 Approval Paradigm

5+ day, 8+ hour ago   (156+ words) By Peter Schmidt, PhD, and Sheldon Preskorn, MD The FDA’s 2026 shift toward making a single pivotal Phase 3 trial the default pathway for drug approval is poised to reshape how CNS therapies are developed, funded, and valued. Rather than relying on…...

EdClinical
clinicalleader.com > doc > the-cost-and-roi-of-agentic-ai-in-clinical-trials-what-sponsors-and-cros-need-to-know-0001

The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know

5+ day, 12+ hour ago   (484+ words) Guest Column | July 21, 2026 By T.G. Prasanna, category specialist – IT & Telecom, Beroe, Inc. This article provides a procurement intelligence framework for clinical operations, quality, finance, and IT leaders at sponsor companies and CROs. It explains how to size investment requirements, distinguish proven…...

EdClinical
clinicalleader.com > doc > reduce-friction-and-save-time-revamp-site-training-to-focus-on-value-over-volume-0001

Reduce Friction And Save Time: Revamp Site Training To Focus On Value Over Volume

5+ day, 20+ hour ago   (356+ words) Guest Column | July 21, 2026 By Ashlin Dunne, MSD; Anne Marie Inglis, GSK; and Ann Katrine Miranda, Novo Nordisk A dermatologist logs into a required training portal and presses play. The video runs for 45 minutes and explains how to perform a punch…...

EdClinical
clinicalleader.com > doc > navigating-choppy-waters-worldwide-flex-delivers-rapid-study-completion-for-anti-nausea-compound-0001

Navigating Choppy Waters: Worldwide Flex Delivers Rapid Study Completion For Anti-Nausea Compound

1+ week, 2+ day ago   (177+ words) Navigating Choppy Waters Worldwide Flex Delivers Rapid Study Completion For Anti-Nausea Compound Clinical Leader Navigating Choppy Waters: Worldwide Flex Delivers Rapid Study Completion For Anti-Nausea Compound Running a clinical trial with 500+ participants enrolled in a single month is tough. Doing…...